Nagendran Sukumar

Taysha Gene Therapies, Inc. · President and Head of R&D

Nagendran Sukumar is listed in public filings as director, officer: President and Head of R&D. This Nagendran Sukumar insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Taysha Gene Therapies, Inc. (TSHA). Investors use Nagendran Sukumar's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Trades

CompanyValueActionPriceCurrent Price
Taysha Gene Therapies, Inc.TSHA$892k200k sharesSellApr 10, 2026$4.46--
Nagendran Sukumar | TradingNote